Andrew Joseph and Damian Garde

BioTech

FDA approves first treatment for ultra-rare bone disease

U.S. regulators on Wednesday approved the first treatment for an ultra-rare disease that causes people to grow bone where it otherwise shouldn’t be, extending an

Andrew Joseph and Damian Garde August 16, 2023

BioTech

In the case of a devastating disease, the FDA weighs an experimental drug’s muddled data and a desperate need

Emma Albee knows the experimental drug she takes is not a cure. It won’t allow her to stop using the wheelchair she’s relied on since

Andrew Joseph and Damian Garde August 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Andrew Joseph and Damian Garde

FDA approves first treatment for ultra-rare bone disease

In the case of a devastating disease, the FDA weighs an experimental drug’s muddled data and a desperate need

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe